REGN•benzinga•
JP Morgan Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $800
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 9, 2025 by benzinga